Significant pathways | Condition | No of genes | No of KEGG genes in pathway | Fold enrichment | Corrected P-value |
---|---|---|---|---|---|
Ribosome | STE | 41 | 193 | 3.03 | 6.90E-09 |
Proteasome | 17 | 50 | 3.51 | 2.30E-03 | |
Ubiquitin mediated proteolysis | 32 | 143 | 2.26 | 3.50E-03 | |
Calcium signaling pathway | 35 | 193 | 2.14 | 4.70E-03 | |
Citrate cycle (TCA cycle) | 16 | 31 | 3.17 | 5.60E-03 | |
Ribosome | LTE | 46 | 193 | 2.15 | 1.71E-05 |
Valine, leucine and isoleucine degradation | 25 | 53 | 2.37 | 4.28E-03 | |
Insulin signaling pathway | 40 | 142 | 1.87 | 1.14E-02 | |
Ubiquitin mediated proteolysis | 37 | 143 | 1.90 | 1.35E-02 | |
Spliceosome | 36 | 136 | 1.87 | 2.02E-02 | |
Ribosome | N | 47 | 193 | 2.61 | 8.80E-09 |
Citrate cycle (TCA cycle) | 19 | 31 | 2.91 | 5.10E-03 | |
Ubiquitin mediated proteolysis | 37 | 143 | 2.08 | 3.50E-03 | |
Valine, leucine and isoleucine degradation | 23 | 53 | 2.45 | 3.50E-03 | |
Focal adhesion | 40 | 204 | 1.92 | 1.20E-02 | |
Endocytosis | 39 | 236 | 1.89 | 1.10E-02 | |
Spliceosome | 33 | 136 | 2.01 | 1.70E-02 | |
Lysosome | 26 | 127 | 2.12 | 1.70E-02 | |
Insulin signaling pathway | 34 | 142 | 1.89 | 4.20E-02 | |
Oocyte meiosis | 25 | 114 | 2.13 | 4.40E-02 |